Remission: Today’s Target in the Treatment of Mood and Anxiety Disorders

Advances in the treatment of mood and anxiety disorders have been significant in recent years. The expectation among psychiatrists that patients can achieve remission is increasing, particularly with the advent of antidepressants with differing modes of action. It was my pleasure to be involved in the development of, and to chair, a series of global neuroscience summit meetings, for which a panel of internationally recognized psychiatrists with academic and clinical expertise in mood and anxiety disorders were brought together to share their knowledge and experience with participants from around the world. The program, developed by the panel, provided an excellent educational and highly interactive forum to discuss clinical and research aspects of unipolar major depressive disorder and anxiety disorders, particularly generalized anxiety disorder. The Global Neuroscience Summit was specifically designed to gain worldwide consensus on key issues relative to response versus remission in the management and treatment of mood and anxiety disorders.